Can Serial FCH-PET/CT Scans Predict the Response to Treatments in Castrate Resistant Prostate Cancer?

Journal of Diagnostic Imaging in Therapy
doi 10.17229/jdit.2018-0303-032
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Open Medscience Limited

Related search

New Therapeutics to Treat Castrate-Resistant Prostate Cancer

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2013English

Guidelines for the Management of Castrate-Resistant Prostate Cancer

Journal of the Canadian Urological Association
OncologyUrology
2010English

Guidelines for the Management of Castrate-Resistant Prostate Cancer

Canadian Urological Association Journal
Urology
2013English

Prognostic Value of 18f-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated With Docetaxel

Contrast Media and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2019English

Management of Docetaxel Failures in Metastatic Castrate-Resistant Prostate Cancer

Urologic Clinics of North America
Urology
2012English

Serial PET-CT Scans Can Help Determine Duration of Antibiotic Therapy After Endovascular Mycotic Thoracic Aortic Aneurysm Repair

Open Journal of Cardiovascular Surgery
2019English

Current Perspectives on Bone Metastases in Castrate-Resistant Prostate Cancer

Cancer and Metastasis Reviews
Cancer ResearchOncology
2018English

Rapid Modulation of PSMA Expression by Androgen Deprivation: Serial 68Ga PSMA-11 PET in Men With Hormone Sensitive and Castrate Resistant Prostate Cancer Commencing Androgen Blockade.

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Molecular Drivers of Metastatic Castrate-Resistant Prostate Cancer: New Roads to Resistance

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy